Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference

Journal of Pharmaceutical Policy and Practice

Nina Zimmermann¹  Guillaume Dedet¹  Valérie Paris¹  Hanne Bak Pedersen¹  Sabine Vogler¹  Veronika J. Wirtz¹  Aukje K. Mantel-Teeuwisse¹  Alessandra Ferrario¹  Kees de Joncheere¹  Zaheer-Ud-Din Babar¹ 

[1] WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Health Economics Department, Gesundheit Österreich GmbH (Austrian Public Health Institute), Vienna, 1010 Austria

关键词: Pricing;    Reimbursement;    Medicine prices;    High-cost medicines;    Biosimilars;    Europe;    Challenges;    Debate;    Cooperation;   

DOI  :  10.1186/s40545-016-0056-8

学科分类：药理学

来源: BioMed Central

【 摘 要 】

In October 2015, the third international Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference was held in Vienna to foster discussion on challenges in pricing and reimbursement policies for medicines. The research presented highlighted that commonly used pharmaceutical pricing and reimbursement policies are not sufficiently effective to address current challenges. Conference participants called for fundamental reforms to ensure access to medicines, particularly to new and potentially more effective and/or safe medicines, while safeguarding the financial sustainability of health systems and working towards universal health coverage.

【 授权许可】

Unknown